Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database by Yu Liu, Lan Ma, Lan Ma, Xiaojia Fu, Xiaojia Fu, Yi Zhang, Yi Zhang, Jinyu Zheng, Zhongjun Chen

Subjects: Get full text

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database by Chang-Zhu He, Qin Qiu, Song-Jie Lu, Fu-Li Xue, Jun-Qiao Liu, Yu He

Subjects: Get full text

Disproportionality analysis and risk factor assessment of drug-associated thyroid dysfunction adverse events: a study based on the FAERS database by Zhifang Wang, Yan Wang, Tingting Wu, Haibin Zhu, Lin Zhang, Xiaolan Liao

Subjects: Get full text

Toxicity spectrum of pegvaliase: A pharmacovigilance analysis using the FAERS database by Luyao Xu, Kaili Mao, Songyang Zhong, Huayu Sun, Hongliang Zheng, Zhenling Fu

Subjects: Get full text

Analysis and mining of Dupilumab adverse events based on FAERS database by Hui Gao, Liqiang Cao, Chengying Liu

Subjects: Get full text

Conducting a real-world study of Tumor Necrosis factor-alpha inhibitors-induced Systemic Lupus Erythematosus based on the FAERS database by Mengjiao He, Jiale Yang, Simin Yan, Qing Shu, Peng Cheng Liu

Subjects: Get full text

Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin by Zhi Wang, Yanhua Lang, Xuyan Liu, Yuxuan Wang, Leping Shao

Subjects: Get full text

Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis by Qian Wang, Hua Lei, Ge Yang, Ying Li, Wei Liu, Lixia Zhang, Xiyuan Zhou

Subjects: Get full text

Adverse drug reactions related to methotrexate: a real-world pharmacovigilance study using the FAERS database from 2004 to 2024 by Siyu Liu, Zhang Yuan, Shicong Rao, Wenxing Li, Taiwei Wu, Shuzhen Deng, Yongying Zhong, Jinyu Lin, Wei Guo, Shiwei Yuan

Subjects: Get full text

Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database by Yating An, Ying Zheng, Ziwei Jiang, Meng Meng, Jintuo Yin, Yahui An

Subjects: Get full text

A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database by Xueping Shi, Chen Wang, Xiang Liu, Li Zou, Pei Guo

Subjects: “…FAERS database…”
Get full text

Signal mining and risk analysis of olanzapine adverse events in the FAERS database by Aiguo Dong, Lingyi Shi, Zhiqiang Du, Qin Zhou, Ying Jiang, Haohao Zhu, Anqing Zhu

Subjects: Get full text

Real-World Pharmacovigilance Analysis of Adverse Events Associated with Liposomal Bupivacaine and Bupivacaine by Chen DX, Chen XM, Chen SM, Wang YD

Subjects: “…faers database…”
Get full text

Evaluation and study of adverse reactions to imiglucerase based on the FAERS database by Pan Hong, Qingbo Zhou

Subjects: Get full text

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system by Yanjun Lu, Qian Xu, Shita Zhu

Subjects: Get full text

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database by Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang

Subjects: Get full text

Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis by Hui Chen

Subjects: Get full text

Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database by Lijuan Song, Nan Yang, Xinglong Xing, Yicong Zhao, Jingkai Di

Subjects: Get full text

Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system by Guihao Zheng, Meifeng Lu, Yulong Ouyang, Shuilin Chen, Bei Hu, Shuai Xu, Guicai Sun

Subjects: Get full text

Mifepristone-related foetal cardiac adverse events: findings from the postmarketing safety reports by Ran Liu, Jihong Wang, Qiong Wang, Yi Zhang, Fengjuan Yuan

Subjects: Get full text